Blocking FASN activity triggers apoptosis in cancer cells and inhibits tumor growth in xenograft models [10], by disrupting lipid membrane synthesis, protein palmitoylation, and signalling of major oncogenic pathways [11,12]. The gene discussed is FASN; the disease is neoplasm.